Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Thirty-month safety update for Xiaflex

Sep. 7, 2012

Affectis Pharmaceuticals presents novel P2X7 receptor antagonists

Sep. 6, 2012

A novel pan-JAK inhibitor shows promise for adjuvant-induced arthritis

Sep. 5, 2012

Protalex reports encouraging results from PRTX-100 trial

Aug. 30, 2012

Multiple novel CCR2 receptor antagonists synthesized at Janssen

Aug. 28, 2012

JAK inhibitor reduces signs and symptoms of arthritis in phase III trials

Aug. 27, 2012

Janssen launches phase III rheumatoid arthritis program

Aug. 24, 2012

FDA extends tofacitinib NDA PDUFA date

Aug. 22, 2012

Eisai divulges new PGE2/EP4 receptor signaling suppressors

Aug. 20, 2012

AnaMar to conduct phase II studies of new analgesic and anti-inflammatory drug

Aug. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...